Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome - PubMed (original) (raw)
Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome
Kirsten Tillisch et al. Am J Gastroenterol. 2005 Apr.
Abstract
Background: Due to a wide range of symptom patterns, patients with irritable bowel syndrome (IBS) are often subgrouped by bowel habit. However, the IBS subgroup with alternating bowel habits (IBS-A) has been poorly characterized.
Objectives: (i) To determine a set of bowel habit symptom criteria, which most specifically identifies IBS patients with an alternating bowel habit, (ii) to describe IBS-A bowel symptom patterns, and (iii) to compare clinical characteristics among IBS-A, constipation-predominant (IBS-C), and diarrhea-predominant IBS (IBS-D).
Methods: One thousand one hundred and two Rome I positive IBS patients were analyzed. Three sets of potential criteria for IBS-A were developed and compared by multirater Kappa test. Gastrointestinal, psychological, extraintestinal symptoms, and health-related quality of life were compared in IBS-A, IBS-C, and IBS-D using chi(2) test and analysis of variance (ANOVA).
Results: Stool consistency was determined to be the most specific criteria for alternating bowel habits. IBS-A patients reported rapid fluctuations in bowel habits with short symptom flares and remissions. There was a greater prevalence of psychological and extraintestinal symptoms in the IBS-A subgroup compared to IBS-C and IBS-D. No differences were seen between bowel habit subtypes in health-related quality of life.
Conclusions: IBS-A patients have rapidly fluctuating symptoms and increased psychological comorbidity, which should be taken into account for clinical practice and clinical trials.
Similar articles
- Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A, Posserud I, Abrahamsson H, Simrén M. Ersryd A, et al. Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61. doi: 10.1111/j.1365-2036.2007.03422.x. Aliment Pharmacol Ther. 2007. PMID: 17767480 - Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Balboa A, Mearin F, Badía X, Benavent J, Caballero AM, Domínguez-Muñoz JE, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M; RITMO Group. Balboa A, et al. Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1271-7. doi: 10.1097/01.meg.0000243870.41207.2f. Eur J Gastroenterol Hepatol. 2006. PMID: 17099375 - Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
Katsinelos P, Lazaraki G, Kountouras J, Paroutoglou G, Oikonomidou I, Mimidis K, Koutras C, Gelas G, Tziomalos K, Zavos C, Pilpilidis I, Chatzimavroudis G. Katsinelos P, et al. Eur J Gastroenterol Hepatol. 2009 Feb;21(2):183-9. doi: 10.1097/MEG.0b013e328312eb97. Eur J Gastroenterol Hepatol. 2009. PMID: 19212207 - A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
Malagelada JR. Malagelada JR. Int J Clin Pract. 2006 Jan;60(1):57-63. doi: 10.1111/j.1368-5031.2005.00744.x. Int J Clin Pract. 2006. PMID: 16409429 Review. - Definition and classification of irritable bowel syndrome: current consensus and controversies.
Longstreth GF. Longstreth GF. Gastroenterol Clin North Am. 2005 Jun;34(2):173-87. doi: 10.1016/j.gtc.2005.02.011. Gastroenterol Clin North Am. 2005. PMID: 15862928 Review.
Cited by
- Irritable bowel syndrome and chronic constipation: emerging drugs, devices, and surgical treatments.
Harris LA, Hansel S, DiBaise J, Crowell MD. Harris LA, et al. Curr Gastroenterol Rep. 2006 Aug;8(4):282-90. doi: 10.1007/s11894-006-0048-y. Curr Gastroenterol Rep. 2006. PMID: 16888869 Review. - Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron.
Gunn D, Garsed K, Lam C, Singh G, Lingaya M, Wahl V, Niesler B, Henry A, Hall IP, Whorwell P, Spiller R. Gunn D, et al. Aliment Pharmacol Ther. 2019 Sep;50(5):538-546. doi: 10.1111/apt.15420. Epub 2019 Jul 24. Aliment Pharmacol Ther. 2019. PMID: 31342534 Free PMC article. Clinical Trial. - Guidelines on the irritable bowel syndrome: mechanisms and practical management.
Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P; Clinical Services Committee of The British Society of Gastroenterology. Spiller R, et al. Gut. 2007 Dec;56(12):1770-98. doi: 10.1136/gut.2007.119446. Epub 2007 May 8. Gut. 2007. PMID: 17488783 Free PMC article. Review. - Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities.
Bond B, Quinlan J, Dukes GE, Mearin F, Clouse RE, Alpers DH. Bond B, et al. Clin Gastroenterol Hepatol. 2009 Jan;7(1):73-9. doi: 10.1016/j.cgh.2008.08.011. Epub 2008 Aug 19. Clin Gastroenterol Hepatol. 2009. PMID: 19124114 Free PMC article. - Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study.
Chassany O, Bonaz B, Bruley DES Varannes S, Bueno L, Cargill G, Coffin B, Ducrotté P, Grangé V. Chassany O, et al. Aliment Pharmacol Ther. 2007 May 1;25(9):1115-23. doi: 10.1111/j.1365-2036.2007.03296.x. Aliment Pharmacol Ther. 2007. PMID: 17439513 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical